LeMaitre Vascular Form 144: 10,815 shares sold via Morgan Stanley

Rhea-AI Filing Summary

LeMaitre Vascular (LMAT) filed a Form 144 reporting a proposed sale of 10,815 common shares on NASDAQ with an aggregate market value of $999,173.07. The form states these shares equal roughly 0.048% of the 22,637,522 shares outstanding. The securities were acquired and are being sold on 08/11/2025 through a stock option exercise, with payment in cash, and the sale is to be executed through Morgan Stanley Smith Barney LLC. The filing notes no securities sold in the past three months by the selling person and includes the filer’s representation that they are unaware of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider exercise and sale of 10,815 shares valued at ~$999K; appears non-material to capitalization.

The Form 144 documents a same-day stock option exercise and sale of 10,815 common shares with an aggregate market value of $999,173.07, executed through Morgan Stanley Smith Barney LLC on NASDAQ. Against 22,637,522 shares outstanding, this position is approximately 0.048% of the company, suggesting the transaction is small relative to the company’s market capitalization. The filer reports no other sales in the prior three months and affirms no undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Disclosure is consistent with Rule 144 requirements; transaction appears procedural rather than governance-significant.

The filing discloses acquisition by stock option exercise and immediate proposed sale, with cash payment and broker identified. Because the filing records no prior sales in the last three months and contains the standard representation about material information, this looks like a compliance-driven disclosure under Rule 144 rather than an indicator of governance or operational concerns. No details in the form identify the seller’s role or prompt governance implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10815	999173.07	22637522	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2025	Stock Option Exercise	Issuer			10815	08/11/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did LMAT file on Form 144?

The Form 144 reports a proposed sale of 10,815 common shares on NASDAQ with an aggregate market value of $999,173.07.

How were the shares acquired according to the filing?

The shares were acquired and are being sold on 08/11/2025 via a stock option exercise, with payment in cash.

Who is the broker handling the proposed sale for LMAT?

The broker named in the filing is Morgan Stanley Smith Barney LLC.

Does the Form 144 show any other sales by the filer in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

What does the filer represent about material information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.